Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Cancer Letters|April 29, 2006
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9Li-Chun Sun, Jing Luo, L Vienna Mackey, et al.
Anti-Cancer Drugs|February 1, 2007
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vectorLi-Chun Sun, Jing Luo, Vienna L Mackey, et al.
Regulatory Peptides|June 2, 2005
Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic isletsCheng-Yu Yao, Manmeet Gill, Catherine A Martens, et al.
Peptides|June 21, 2007
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cellsTerry W Moody, Samuel A Mantey, Joseph A Fuselier, et al.
Retina (Philadelphia, Pa.)|April 5, 2005
Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in ratsYanno Bezerra, Joseph A Fuselier, Gholam A Peyman, et al.
Diabetes|November 23, 2011
Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic ratsJessica T Y Yue, Elena Burdett, David H Coy, et al.
American Journal of Translational Research|April 12, 2021
The COVID-19 pandemic and the potential treatment of the novel coronavirus SARS-CoV-2Shilei Wang, Jinlei Ye, Zhichao Kang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 21, 2014
Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancerYuanyuan Gao, Yan Wang, Lichun Sun, et al.
Clinical Epigenetics|May 18, 2021
NEFM DNA methylation correlates with immune infiltration and survival in breast cancerDandan Li, Wenhao Zhao, Xinyu Zhang, et al.
Molecular and Cellular Biochemistry|November 18, 2010
Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90Qingwei Meng, Xuesong Chen, Lichun Sun, et al.
Pageof 12